Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;35(Suppl 1):33-41.
doi: 10.1007/s40273-017-0546-9.

The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment

Affiliations
Free article
Review

The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment

Donna Rowen et al. Pharmacoeconomics. 2017 Dec.
Free article

Abstract

A condition-specific preference-based measure (CSPBM) is a measure of health-related quality of life (HRQOL) that is specific to a certain condition or disease and that can be used to obtain the quality adjustment weight of the quality-adjusted life-year (QALY) for use in economic models. This article provides an overview of the role and the development of CSPBMs, and presents a description of existing CSPBMs in the literature. The article also provides an overview of the psychometric properties of CSPBMs in comparison with generic preference-based measures (generic PBMs), and considers the advantages and disadvantages of CSPBMs in comparison with generic PBMs. CSPBMs typically include dimensions that are important for that condition but may not be important across all patient groups. There are a large number of CSPBMs across a wide range of conditions, and these vary from covering a wide range of dimensions to more symptomatic or uni-dimensional measures. Psychometric evidence is limited but suggests that CSPBMs offer an advantage in more accurate measurement of milder health states. The mean change and standard deviation can differ for CSPBMs and generic PBMs, and this may impact on incremental cost-effectiveness ratios. CSPBMs have a useful role in HTA where a generic PBM is not appropriate, sensitive or responsive. However, due to issues of comparability across different patient groups and interventions, their usage in health technology assessment is often limited to conditions where it is inappropriate to use a generic PBM or sensitivity analyses.

PubMed Disclaimer

References

    1. Health Qual Life Outcomes. 2005 Mar 15;3:13 - PubMed
    1. Qual Life Res. 2008 Apr;17(3):453-62 - PubMed
    1. Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):218-23 - PubMed
    1. JAMA Ophthalmol. 2014 Mar;132(3):310-8 - PubMed
    1. Value Health. 2015 Sep;18(6):846-55 - PubMed

LinkOut - more resources